MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SLN made $5,446,000 in revenue. -$20,958,000 in net income. Net profit margin of -384.83%.

Income Overview

Revenue
$5,446,000
Net Income
-$20,958,000
Net Profit Margin
-384.83%
EPS
-$0.15
Unit: Dollar
Revenue Breakdown
    • Benefit from r&d credit
    • Foreign currency gain/(loss), ne...
    • Other income, net
    • Revenue

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
--142,000 10,814,500
Segment reporting, other segment item, amount
--121,000 4,713,750
Other r&d costs
-936,000 584,000 1,119,500
Personnel research and development costs
-4,479,000 5,556,000 5,125,750
Contracted development costs
-12,232,000 14,673,000 10,725,500
Revenue
159,000 ---
Cost of sales
64,000 -54,000 2,952,500
Gross profit
95,000 ---
Research and development costs
20,544,000 ---
General and administrative expenses
5,795,000 -7,684,000 6,721,000
Restructuring charges
0 ---
Operating loss
-26,244,000 ---
Foreign currency gain/(loss), net
1,934,000 ---
Other income, net
770,000 ---
Benefit from r&d credit
2,583,000 ---
Loss before income tax expense
-20,957,000 ---
Income tax expense
1,000 --211,250
Net loss
-20,958,000 -27,354,000 -28,530,000 -11,327,250
Earnings per share, basic
-0.15 -0.19 -0.2 -0.083
Earnings per share, diluted
-0.15 -0.19 -0.2 -0.083
Weighted average number of shares outstanding, basic
141,701,848 141,696,047 141,678,734 34,688,056
Weighted average number of shares outstanding, diluted
141,701,848 141,696,047 141,678,734 34,688,056
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$20,958,000 Income tax expense$1,000 Loss before incometax expense-$20,957,000 Benefit from r&d credit$2,583,000 Other income, net$770,000 Foreign currencygain/(loss), net$1,934,000 Revenue$159,000 Operating loss-$26,244,000 Gross profit$95,000 Cost of sales$64,000 General andadministrative expenses$5,795,000 Research and developmentcosts$20,544,000

Silence Therapeutics plc (SLN)

Silence Therapeutics plc (SLN)